STAM2 Antibody

What is STAM2 and why is it important in cellular research?

STAM2 is a signal-transducing adaptor molecule that plays crucial roles in cytokine and growth factor signaling pathways. It functions downstream of Janus kinases (JAKs) and is involved in regulating gene expression through transcription factors such as c-Myc, which is essential for cell proliferation and survival . STAM2 undergoes tyrosine phosphorylation by JAK3 and JAK2 upon cytokine stimulation, which is vital for signal transduction . Additionally, STAM2 forms part of the ESCRT-0 complex with HGS, which binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors for lysosomal trafficking .

What applications are STAM2 antibodies suitable for?

STAM2 antibodies are validated for multiple research applications:

What is the observed molecular weight of STAM2 in Western blot applications?

While the calculated molecular weight of STAM2 is approximately 58 kDa, the observed molecular weight in Western blot applications is typically between 68-70 kDa . This discrepancy may be due to post-translational modifications or the presence of different isoforms. When performing Western blot analysis, researchers should expect to see a band at approximately 70 kDa for endogenous STAM2 .

What are the recommended protocols for immunohistochemical detection of STAM2?

For optimal immunohistochemical detection of STAM2:

• Perform heat-mediated antigen retrieval with TE buffer pH 9.0 before commencing with IHC staining protocol. Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 .

• Use a dilution range of 1:50-1:500 depending on the specific antibody and sample type .

• For evaluation of STAM2 expression levels in tissue, grade both the percentage of cells staining positively and their staining intensity on a scale of 0-3, then multiply to give a staining index: 0=none; 1-3=low; 4-6=moderate and 9=high .

• Include appropriate positive controls such as known STAM2-expressing tissues like mouse heart or kidney tissue .

How should researchers design flow cytometry experiments to detect STAM2?

When designing flow cytometry experiments for STAM2 detection:

• Fix cells with either 80% methanol (5 min) or 4% paraformaldehyde (10 min) .

• Permeabilize with 0.1% PBS-Tween for 20 minutes, as STAM2 is primarily an intracellular protein .

• Block non-specific protein interactions with 1x PBS / 10% normal goat serum / 0.3M glycine .

• Incubate with primary STAM2 antibody at appropriate dilution (e.g., 1:10000 for certain antibodies) for 30 minutes at 22°C .

• Use appropriate fluorophore-conjugated secondary antibodies (e.g., Alexa Fluor 488 goat anti-rabbit IgG) at 1:2000 dilution .

• Include isotype control antibody and unlabelled sample as controls .

• Collect >5,000 events using appropriate laser and filter settings (e.g., 20mW Argon ion laser at 488nm with 525/30 bandpass filter) .

How can STAM2 antibodies be used to study its role in T-cell development and function?

STAM2 plays a significant role in T-cell development, as demonstrated in knockout studies. For comprehensive investigation:

• Use STAM2 antibodies in combination with T-cell markers for multi-parameter flow cytometry to assess STAM2 expression levels at different stages of T-cell development.

• Consider double-staining with markers such as CD4 and CD8 to analyze STAM2 distribution in different T-cell populations .

• For functional studies, compare wild-type with STAM2-depleted or knockout cells in proliferation assays upon stimulation with T-cell receptor (TCR) antibodies and/or cytokines like IL-2 and IL-7 .

• Assess downstream signaling events such as STAT5, ERK, and PKB/Akt activation, and c-myc induction in response to cytokine stimulation .

• For advanced in vivo studies, consider tissue-specific knockout models using Cre/loxP systems, as complete STAM1/STAM2 double knockout is embryonically lethal .

What approaches can be used to study STAM2's interaction with the ESCRT-0 complex and its role in receptor trafficking?

To investigate STAM2's role in the ESCRT-0 complex and receptor trafficking:

• Use co-immunoprecipitation with STAM2 antibodies to pull down associated proteins like HGS and analyze the composition of the ESCRT-0 complex .

• Perform immunofluorescence studies with STAM2 antibodies to examine co-localization with endosomal markers such as EEA1 .

• Combine with siRNA-mediated knockdown of STAM2 to observe effects on receptor trafficking and Golgi morphology .

• For detailed analysis of STAM2's role in COPII complexes, immunostain for endogenous Sec31A, Sec24, and Sec16L in cells manipulated for STAM2 expression .

• Assess the effects of STAM2 knockdown on cellular organelles using appropriate markers for Golgi (GM130, GGA3, CIMPR), mitochondria (cytochrome c), and cytoskeleton (tubulin, actin) .

How should researchers interpret variations in STAM2 expression patterns across different cell types and tissues?

When analyzing STAM2 expression patterns:

• Consider that STAM2 exhibits both cytoplasmic and perinuclear localization patterns, with more prominent perinuclear enrichment compared to STAM1 .

• Note that STAM2 partially co-localizes with early endosomal marker EEA1 but also shows distinct distribution patterns .

• When comparing expression across tissues, validate antibody specificity using siRNA-mediated depletion of STAM2 as a negative control .

• In tumor tissues such as gastrointestinal stromal tumors (GISTs), consider correlating STAM2 expression with other markers like CD117 (KIT) and proliferation markers such as Ki-67 .

• When analyzing mitotic count correlation with STAM2 expression, note that previous studies have found a negative correlation (r=-0.362, p<0.01) .

What controls should be included when interpreting STAM2 antibody staining in experimental studies?

To ensure reliable interpretation of STAM2 antibody staining:

• Include positive controls using cell lines or tissues known to express STAM2 (e.g., HeLa cells, HepG2 cells, mouse brain tissue) .

• Incorporate negative controls such as:

  • Isotype control antibodies at matching concentrations

  • Samples with STAM2 knockdown using validated siRNA

  • Secondary antibody-only controls to assess background staining

• For quantitative analysis of staining intensity, include calibration standards and ensure consistent imaging parameters across all samples.

• When analyzing co-localization with other proteins, include appropriate single-stained controls to account for spectral overlap in fluorescence microscopy.

• Consider cell cycle phase when interpreting STAM2 expression, as levels may vary during different phases.

What are common issues with STAM2 antibody applications and how can they be resolved?

How does the choice between monoclonal and polyclonal STAM2 antibodies affect experimental outcomes?

The choice between monoclonal and polyclonal STAM2 antibodies significantly impacts experimental design and outcomes:

Monoclonal antibodies (e.g., EPR8688 , F-11 ):

• Provide high specificity for a single epitope, reducing cross-reactivity

• Offer batch-to-batch consistency, enhancing reproducibility across experiments

• May have reduced sensitivity if their specific epitope is masked or modified

• Particularly valuable for applications requiring high specificity such as therapeutic target validation

Polyclonal antibodies (e.g., 13009-1-AP , ABIN6265306 ):

• Recognize multiple epitopes, potentially increasing detection sensitivity

• May provide more robust signals when protein conformation is altered by fixation or denaturation

• Show greater batch-to-batch variation, requiring more rigorous validation

• Offer advantages when studying proteins with post-translational modifications or conformational changes

For critical research:

• Consider validating key findings with both antibody types

• For novel applications, test multiple antibodies targeting different regions of STAM2

• For co-immunoprecipitation studies, anti-STAM1 antibodies have shown better efficacy than anti-STAM2 antibodies in some preliminary studies